Latest News in the pharma Industry

All

Centrient Pharmaceuticals Receives Gold Sustainability Rating from EcoVadis

Centrient Pharmaceuticals Receives Gold Sustainability Rating from EcoVadis

25 Sep 2020

Centrient Pharmaceuticals Receives Gold Sustainability Rating from EcoVadis

Read more 
Marchesini Group Press Kit 2020

Marchesini Group Press Kit 2020

25 Sep 2020

With a turnover of 441 million Euro in 2019 and 2,000 employees in Italy and abroad, Marchesini Group is a flagship of the Packaging Valley in Emilia Romagna and one of the top four worldwide manufacturers of automatic pharmaceutical and cosmetic packa...

Read more 
New study further validates Bioiberica’s b-2Cool® native type II collagen as trusted source for holistic mobility solutions

New study further validates Bioiberica’s b-2Cool® native type II collagen as trusted source for holistic mobility solutions

25 Sep 2020

New scientific research, published in Osteoarthritis and Cartilage, highlights the benefits of Bioiberica’s native (undenatured) type II collagen (b-2Cool®) in combination with other key ingredients for joint health: chondroitin sulphate, glucosamin...

Read more 
HK inno.N Corporation receives regulatory approval for first novel drug

HK inno.N Corporation receives regulatory approval for first novel drug

24 Sep 2020

Korean pharmaceutical firm HK inno.N Corp. said on Friday that its gastroesophageal reflux disease drug K-CAB has been approved by the Ministry of Food and Drug Safety, marking the first time for the company to launch an independently-developed novel d...

Read more 
Almac Group Launches Biologics Testing Solutions

Almac Group Launches Biologics Testing Solutions

24 Sep 2020

Athlone, Ireland - 15 September 2020 –  Almac Sciences, a member of Almac Group, has announced the expansion of its existing suite of analytical solutions to include biologics testing.

Read more 
Usin Near-Infrared spectroscopy and chemometric modeling to simultaneously determine ibuprofen and caffeine concentration in softgels

Usin Near-Infrared spectroscopy and chemometric modeling to simultaneously determine ibuprofen and caffeine concentration in softgels

24 Sep 2020

Appearing in the September 2020 edition of Tablets & Capsules, this article summarizes a method for rapid and accurate determination of API concentration in the fill of soft gelatin capsules while little or no sample preparation. Applying chemometric m...

Read more 
Xellia's response to the COVID-19 outbreak

Xellia's response to the COVID-19 outbreak

24 Sep 2020

Xellia's response to the COVID-19 outbreak

Read more 
Xellia Pharmaceuticals Opens New Commercial Office in Dubai

Xellia Pharmaceuticals Opens New Commercial Office in Dubai

24 Sep 2020

Xellia Pharmaceuticals Opens New Commercial Office in Dubai

Read more 
Expanding workforce at the Cleveland manufacturing site

Expanding workforce at the Cleveland manufacturing site

24 Sep 2020

Xellia Pharmaceuticals is recruiting an additional 100 employees to expand workforce at its Cleveland, Ohio manufacturing site

Read more 
The release of Xellia's global recruitment film

The release of Xellia's global recruitment film

23 Sep 2020

Watch Xellia's global recruitment film: Our Culture, Our Values, Our Purpose - Being an Xellian

Read more 
Samyang Biopharm USA, Inc and CanCure LLC Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic

Samyang Biopharm USA, Inc and CanCure LLC Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic

23 Sep 2020

Samyang Biopharm USA, Inc. (https://us.samyangbiopharm.com) a global biotech subsidiary of the Samyang Pharmaceuticals Corp. (https://samyangbiopharm.com/eng), announced today that the company has entered into a worldwide licensing agreement with CanCu...

Read more 
Samyang Biopharm USA in-licenses Talix Therapeutics’ first-in-class compound

Samyang Biopharm USA in-licenses Talix Therapeutics’ first-in-class compound

23 Sep 2020

Samyang Biopharm USA has licensed in Belgium’s Talix Therapeutics’ first-in-class immuno-oncology compound for global rights.

Read more